Christie Mitchell Ballantyne

Christie Mitchell Ballantyne, M.D.

Section Chief of Cardiology and Cardiovascular Research

Email

cmb@bcm.edu

Positions

Section Chief of Cardiology and Cardiovascular Research: ��Ƶ of Medicine

Professor: Medicine- Cardiology and Molecular and Human Genetics
��Ƶ of Medicine

Professor: Molecular Physiology and Biophysics
��Ƶ of Medicine

Director: The Maria and Alando J. Ballantyne, M.D. Atherosclerosis Clinical Research Laboratory
��Ƶ of Medicine

Director: Center for Cardiometabolic Disease Prevention
��Ƶ of Medicine

Co-Director: Lipid Metabolism and Atherosclerosis Clinic
��Ƶ of Medicine

J. S. Abercrombie Chair - Atherosclerosis and Lipoprotein Research: ��Ƶ of Medicine

Chief, Cardiovascular Research and Cardiology: Medicine
��Ƶ of Medicine

Addresses

Section of Cardiovascular Research (Office): One Baylor Plaza, MS BCM285
Suite 524D
Houston, TX, 77030
United States
Phone: (713) 798-5034
/departments/medicine/sections-and-divisions/cardiovascular-research

Center for Cardiometabolic Disease Prevention (Clinic): 6655 Travis Street, Suite 320
Houston, TX, 77030
United States
Phone: (713) 798-5800
/healthcare/specialties/cardiovascular-medicine/you-and-your-heart/general-cardiology/lipid-metabolism-and-atherosclerosis-clinic

Education

Fellowship at Howard Hughes Medical Institute and Institute for Molecular Genetics, ��Ƶ of Medicine: 01/1989 - Houston, TX, United States

Clinical Fellowship at ��Ƶ Of Medicine Affiliate Hospitals: 01/1987 - Houston, TX, United States; Cardiology

Residency at University Of Texas Southwestern Affiliate Hospitals: 01/1985 - Dallas, TX, United States; Internal Medicine

Internship at University of Texas Southwestern Medical School: Dallas, Texas, United States

MD from ��Ƶ Of Medicine: 01/1982 - Houston, TX, United States

BA from University Of Texas At Austin: 01/1977 - Austin, TX, United States

Certifications

Cardiovascular Disease: American Board of Internal Medicine

Internal Medicine: American Board of Internal Medicine

Diplomate: American Board of Clinical Lipidology

Honors & Awards

2024 Top Doctor: Castle Connolly

President: National Lipid Association (06/2024)

Distinguished Scientist Award: American Heart Association (11/2025)

Professional Interests

Clinical and translational research in patients with hereditary lipid disorders for the prevention and treatment of cardiometabolic disease and genetic epidemiology related to lipids and cardiometabolic disease
Preventive Cardiology
Atherosclerosis
Lipid Disorders
Cardiovascular Disease Prevention

Professional Statement

Dr. Ballantyne's clinical research focuses on the prevention of cardiometabolic disease. This interest includes pharmacological studies to assess the efficacy and benefits of lipid-lowering drug therapy including trials that examine the effects of lipid-lowering drugs on cardiovascular disease events and the progression of atherosclerosis. As the director of The Maria and Alando J. Ballantyne, M.D., Atherosclerosis Clinical Research Laboratory, which serves as the core laboratory for the Atherosclerosis Risk in Communities study, Dr. Ballantyne is studying whether genetic variants in combination with novel biomarkers might be useful in identifying individuals at high risk for cardiometabolic disease and diabetes. Genomics, proteomics, and metabolomics are being used to identify novel molecules that are increased with atherosclerosis, obesity, diabetes, and cardiometabolic disease. In addition, his group is studying new approaches to the prevention and treatment of cardiometabolic diseases with the goal of developing personalized diet, lifestyle, and pharmacotherapy based on the genetic profile and clinical phenotype assessed by proteomics, metabolomics, and imaging.

Websites

Center for Cardiometabolic Disease Prevention

Division of Atherosclerosis and Vascular Medicine

Section of Cardiology

Department of Integrative Physiology

Department of Molecular and Human Genetics

Graduate Program in Molecular Physiology & Biophysics

Molecular Physiology of the Cardiovascular System

Graduate Program in Translational Biology and Molecular Medicine

Cardiovascular Research Institute

Lipid Metabolism and Atherosclerosis Clinic

Selected Publications

Ballantyne CM, Laufs U, Ray KK, Leiter LA, Bays HE, Goldberg AC, Stroes ES, MacDougall D, Zhao X, Catapano AL. " " Eur J Prev Cardiol. 2020 ; 27 : 593-603.
Pubmed PMID: .
Tang O, Daya N, Matsushita K, Coresh J, Sharrett AR, Hoogeveen R, Jia X, Windham BG, Ballantyne C, Selvin E. " " Diabetes Care. 2020 ; 43 : 1200-8.
Pubmed PMID: .
Peterson BE, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Tardif JC, Verma S, Ballantyne CM, on behalf of the REDUCE-IT Investigators. " Reduction in revascularization with icosapent ethyl: insights from REDUCE-IT revascularization analyses. " Circulation. 2021 ; 143 : 33-44.
Antony A, Lian Z, Perrard XD, Perrard J, Liu H, Cox AR, Saha P, Hennighausen L, Hartig SM, Ballantyne CM, Wu H. " " Diabetes. 2021 ; 70 : 720-32.
Pubmed PMID: .
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Gregson J, Pocock SJ, Ballantyne CM, on behalf of the REDUCE-IT Investigators. " " J Am Coll Cardiol. 2019 ; 73 : 2791-802.
Pubmed PMID: .
Ray KK, Bays HE, Catapano AL, Lalwani ND, Bloedon LT, Sterling LR, Robinson PL, Ballantyne CM, for the CLEAR Harmony Trial. " Safety and efficacy of bempedoic acid to reduce LDL cholesterol. " N Engl J Med. 2019 ; 380 : 1022-32.
Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, Heiss G, Couper DJ, Solomon SD, Boerwinkle E, Shah A, Selvin E, de Lemos JA, Ballantyne CM. " " Circulation. 2019 ; 139 : 2642-53.
Pubmed PMID: .
Virani SS, Akeroyd JM, Nambi V, Michos ED, Morris PB, Nasir K, Smith SC, Stone NJ, Petersen LA, Ballantyne CM. " " Circulation. 2019 ; 139 : 410-2.
Pubmed PMID: .
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM, for the REDUCE-IT Investigators. " " N Engl J Med. 2019 ; 380 : 11-22.
Pubmed PMID: .
Saeed A, Nambi V, Sun W, Virani SS, Taffet G, Deswal A, Selvin E, Matsushita K, Wagenknecht LE, Hoogeveen R, Coresh J, de Lemos JA, Ballantyne CM. " Short-term global cardiovascular disease risk prediction in older adults. " J Am Coll Cardiol. 2018 ; 71 : 2527-36.

to edit your profile

������Ƶ